Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Element Materials Technology Oakland-Concord
FDA Inspection
•Element Materials Technology Oakland-Concord•March 22, 2022

Element Materials Technology Oakland-Concord – FDA Inspection, Mar 22, 2022

Record Details

This FDA Inspection record concerns Element Materials Technology Oakland-Concord, with an inspection on March 22, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Element Materials Technology Oakland-Concord
Inspection Date
March 22, 2022
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · c631aa71-8bb0-4b76-b533-eb581e305d7e

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1165719
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

14
  1. 21 CFR 211.46(a)Adequate ventilation not provided
  2. 21 CFR 211.42(c)(10)(iii)Air Supply
  3. 21 CFR 211.42(c)(10)(v)Cleaning System
  4. 21 CFR 211.58Buildings not maintained in good state of repair
  5. 21 CFR 211.48(b)Drains--Size, Back-siphonage Prevention
  6. 21 CFR 211.46(b)Equipment for Environmental Control
  7. 21 CFR 211.160(b)Scientifically sound laboratory controls
  8. 21 CFR 211.113(b)Validation lacking for sterile drug products
  9. 21 CFR 211.67(b)(5)Cleaning SOPs/equipment protection
  10. 21 CFR 211.68(a)Calibration/Inspection/Checking not done

Showing 10 of 14 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Element Materials Technology Oakland-Concord

4
DateClassificationOfficeProject area
January 30, 2026OAISan Francisco District OfficeDrug Quality Assurance
December 21, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 8, 2014VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 16, 2009NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Element Materials Technology Oakland-Concord
  • FDA Inspection 1300524 - 2026-01-30
  • FDA Inspection 1076021 - 2018-12-21
  • FDA Inspection 889833 - 2014-07-08
  • FDA Inspection 589823 - 2009-06-16

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Element Materials Technology Oakland-Concord
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.